439
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability

, , , , &
Pages 183-193 | Received 29 Jun 2015, Accepted 27 Oct 2015, Published online: 26 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kazuhiro Ito. (2022) Inhaled antifungal therapy: benefits, challenges, and clinical applications. Expert Opinion on Drug Delivery 19:7, pages 755-769.
Read now

Articles from other publishers (25)

Qingzhen Zhang, Shanglong Kou, Yingtong Cui, Jie Dong, Yuqing Ye, Yuanyuan Wang, Rui Lu, Xinduo Li, Yi Nie, Kaiqi Shi, Fang Chen, Philip Hall, Xiaoling Chen, Zheng Wang & Xingtao Jiang. (2023) Ternary Dry Powder Agglomerate Inhalation Formulation of Melatonin With Air Jet Mixing to Improve In Vitro And In Vivo Performance. Journal of Pharmaceutical Sciences.
Crossref
Shahjabeen Sharif, Saiqa Muneer, Tony Wang, Emad L. Izake & Nazrul Islam. (2022) Robust Wet Milling Technique for Producing Micronized Ibuprofen Particles with Improved Solubility and Dissolution. AAPS PharmSciTech 24:1.
Crossref
Menghuan Zhu, Dongna Zhang, Lili Zhang, Liangliang Zhao, Likun Xu, Baogang Wang, Xinyu Zhang, Jinwei Chen, Zhuchun Bei, Hong Wang, Dongsheng Zhou, Wenhui Yang & Yabin Song. (2022) Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model. Pharmaceutics 14:12, pages 2646.
Crossref
Amanpreet Kaur, Gurudutt Dubey, Nisha Sharma, Rajat Pant, Prasad V. Bharatam, Kulbhushan Tikoo & Arvind K. Bansal. (2022) High dose nanocrystalline solid dispersion powder of voriconazole for inhalation. International Journal of Pharmaceutics 622, pages 121827.
Crossref
Benjamin KablyManon LaunayAudrey DerobertmasureSandrine Lefeuvre, Eric DannaouiEliane M. Billaud. (2022) Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring 44:1, pages 166-197.
Crossref
Khaled Almansour, Iman M. Alfagih, Alhassan H. Aodah, Fawaz Alheibshy, Raisuddin Ali, Turki Al Hagbani & Mustafa M.A. Elsayed. (2021) Inhalable, Spray-Dried Terbinafine Microparticles for Management of Pulmonary Fungal Infections: Optimization of the Excipient Composition and Selection of an Inhalation Device. Pharmaceutics 14:1, pages 87.
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2021) Leucine as an excipient in spray dried powder for inhalation. Drug Discovery Today 26:10, pages 2384-2396.
Crossref
Shadi Yaqoubi, Hak-Kim Chan, Ali Nokhodchi, Siavoush Dastmalchi, Ali Akbar Alizadeh, Mohammad Barzegar-Jalali, Khosro Adibkia & Hamed Hamishehkar. (2021) A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols. International Journal of Pharmaceutics 602, pages 120568.
Crossref
Qiuying Liao & Jenny K.W. Lam. (2021) Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses. Current Pharmaceutical Design 27:12, pages 1453-1468.
Crossref
Ranjot Kaur, Sarah R. Dennison, Andrea J. Burrow, Shivaprakash M. Rudramurthy, Rajan Swami, Varun Gorki, O. P. Katare, Anupama Kaushik, Bhupinder Singh & Kamalinder K. Singh. (2021) Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention. Journal of Nanobiotechnology 19:1.
Crossref
Mellissa Gomez, Joseph McCollum, Hui Wang, Mani Ordoubadi, Chester Jar, Nicholas B. Carrigy, David Barona, Isobel Tetreau, Michelle Archer, Alana Gerhardt, Chris Press, Christopher B. Fox, Ryan M. Kramer & Reinhard Vehring. (2021) Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. International Journal of Pharmaceutics 593, pages 120121.
Crossref
Khaled Almansour, Iman M. Alfagih, Raisuddin Ali & Mustafa M.A. Elsayed. (2020) Inhalable microparticles containing terbinafine for management of pulmonary fungal infections: Spray drying process engineering using lactose vs. mannitol as excipients. Journal of Drug Delivery Science and Technology 60, pages 101991.
Crossref
Shen Nam Cheng, Zhi Guang Tan, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain & Hira Choudhury. (2020) A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis. Pharmaceutics 12:12, pages 1161.
Crossref
Renata Ribeiro de Castro, Valério Todaro, Luiz Claudio Rodrigues Pereira da Silva, Alice Simon, Flavia Almada do Carmo, Valeria Pereira de Sousa, Carlos Rangel Rodrigues, Bruno Sarmento, Anne Marie Healy & Lucio Mendes Cabral. (2020) Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis. Journal of Drug Delivery Science and Technology 58, pages 101805.
Crossref
Poonam Singh Thakur, Samarth D. Thakore & Arvind K. Bansal. (2020) Role of Surface Characteristics of Mannitol in Crystallization of Fenofibrate During Spray Drying. Journal of Pharmaceutical Sciences 109:2, pages 1105-1114.
Crossref
Kajal Pawar, Rutuja Gadhave, Swati Waydande & Pravin Pawar. (2019) Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications. Drug Delivery Letters 9:3, pages 199-210.
Crossref
Chaeho Moon, Alan B. Watts, Xingyu Lu, Yongchao Su & Robert O. WilliamsIIIIII. (2019) Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation. Molecular Pharmaceutics 16:5, pages 1799-1812.
Crossref
Qiuying Liao, Long Yip, Michael Y.T. Chow, Shing Fung Chow, Hak-Kim Chan, Philip C.L. Kwok & Jenny K.W. Lam. (2019) Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition. International Journal of Pharmaceutics 560, pages 144-154.
Crossref
Nivedita Shetty, Patricia Ahn, Heejun Park, Sonal Bhujbal, Dmitry Zemlyanov, Alex Cavallaro, Sharad Mangal, Jian Li & Qi Tony Zhou. (2018) Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin. Molecular Pharmaceutics 15:9, pages 4004-4020.
Crossref
Stephen P. Newman. (2018) Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases. Advanced Drug Delivery Reviews 133, pages 5-18.
Crossref
Nivedita Shetty, Heejun Park, Dmitry Zemlyanov, Sharad Mangal, Sonal Bhujbal & Qi (Tony) Zhou. (2018) Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. International Journal of Pharmaceutics 544:1, pages 222-234.
Crossref
Sharad Mangal, Haichen Nie, Rongkun Xu, Rui Guo, Alex Cavallaro, Dmitry Zemlyanov & Qi Zhou. (2018) Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation. Pharmaceutical Research 35:2.
Crossref
Genki Kimura, Takahiro Nakaoki, Thomas Colley, Garth Rapeport, Pete Strong, Kazuhiro Ito & Yasuo Kizawa. (2017) In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice . Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Michael Y.T. Chow, Yingshan Qiu, Fiona F.K. Lo, Hinson H.S. Lin, Hak-Kim Chan, Philip C.L. Kwok & Jenny K.W. Lam. (2017) Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. International Journal of Pharmaceutics 530:1-2, pages 40-52.
Crossref
Stephen P Newman. (2017) Drug delivery to the lungs: challenges and opportunities. Therapeutic Delivery 8:8, pages 647-661.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.